Cardiovascular disease (CVD) outcomes and associated risk factors in a medicare population without prior CVD history: an analysis using statistical and machine learning algorithms.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
08 2023
Historique:
received: 07 02 2023
accepted: 26 04 2023
medline: 10 8 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

There is limited information on predicting incident cardiovascular outcomes among high- to very high-risk populations such as the elderly (≥ 65 years) in the absence of prior cardiovascular disease and the presence of non-cardiovascular multi-morbidity. We hypothesized that statistical/machine learning modeling can improve risk prediction, thus helping inform care management strategies. We defined a population from the Medicare health plan, a US government-funded program mostly for the elderly and varied levels of non-cardiovascular multi-morbidity. Participants were screened for cardiovascular disease (CVD), coronary or peripheral artery disease (CAD or PAD), heart failure (HF), atrial fibrillation (AF), ischemic stroke (IS), transient ischemic attack (TIA), and myocardial infarction (MI) for a 3-yr period in the comorbid history. They were followed up for up to 45.2 months. Analyses included descriptive approaches in terms of incidence rates and density ratios, and inferential in terms of main effect statistical/complex machine learning modeling. The contemporary risk factors of interest spanned across the domains of comorbidity, lifestyle, and healthcare utilization history. The cohort consisted of 154,551 individuals (mean age 68.8 years; 62.2% female). The overall crude incidence rate of CVD events was 9.9 new cases per 100 person-years. The highest rates among its component outcomes were obtained for CAD or PAD (3.6 for each), followed by HF (2.2) and AF (1.8), then IS (1.3), and finally TIA (1.0) and MI (0.9).Model performance was modest in terms of discriminatory power (C index: 0.67, 95%CI 0.667-0.674 for training; and 0.668, 95%CI 0.663-0.673 for validation data), equal agreement between predicted and observed events for calibration purposes, and good clinical utility in terms of a net benefit of 15 true positives per 100 patients relative to the All-patient treatment strategy. Complex models based on machine learning algorithms yielded incrementally better discriminatory power and much improved goodness-of-fitness tests from those based on main effect statistical modeling. This Medicare population represents a highly vulnerable group for incident CVD events. This population would benefit from an integrated approach to their care and management, including attention to their comorbidities and lifestyle factors, as well as medication adherence.

Identifiants

pubmed: 37296355
doi: 10.1007/s11739-023-03297-6
pii: 10.1007/s11739-023-03297-6
pmc: PMC10255946
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

1373-1383

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Società Italiana di Medicina Interna (SIMI).

Références

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
doi: 10.1016/j.jacc.2020.11.010 pubmed: 33309175 pmcid: 7755038
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P (2008) Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 94(1):34–39. https://doi.org/10.1136/hrt.2007.134890
doi: 10.1136/hrt.2007.134890 pubmed: 17916661
Hippisley-Cox J, Coupland C, Brindle P (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.j2099
doi: 10.1136/bmj.j2099 pubmed: 29158232 pmcid: 5694979
Anderson KM, Odell PM, Wilson PWF, Kannel WB (1991) Cardiovascular disease risk profiles. Am Heart J 121:293–298
doi: 10.1016/0002-8703(91)90861-B pubmed: 1985385
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB (2008) General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117(6):743–753. https://doi.org/10.1161/CIRCULATIONAHA.107.699579
doi: 10.1161/CIRCULATIONAHA.107.699579 pubmed: 18212285
Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003
doi: 10.1016/S0195-668X(03)00114-3 pubmed: 12788299
SCORE2 working group and ESC Cardiovascular risk collaboration (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42(25):2439–2454. https://doi.org/10.1093/eurheartj/ehab309
doi: 10.1093/eurheartj/ehab309
Pylypchuk R, Wells S, Kerr A, Poppe K, Riddell T, Harwood M, Exeter D, Mehta S, Grey C, Wu BP, Metcalf P, Warren J, Harrison J, Marshall R, Jackson R (2018) Cardiovascular disease risk prediction equations in 400000 primary care patients in New Zealand: a derivation and validation study. Lancet 391:1897–1907
doi: 10.1016/S0140-6736(18)30664-0 pubmed: 29735391
Neumann JT, Thao LTP, Callander E, Chowdhury E, Williamson JD, Nelson MR, Donnan G, Woods RL, Reid CM, Poppe KK, Jackson R, Tonkin AM, McNeil JJ (2022) Cardiovascular risk prediction in healthy older people. Geroscience 44(1):403–413. https://doi.org/10.1007/s11357-021-00486-z
doi: 10.1007/s11357-021-00486-z pubmed: 34762275
Burdett P, Lip GYH (2022) Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes 8(2):187–194. https://doi.org/10.1093/ehjqcco/qcaa093
doi: 10.1093/ehjqcco/qcaa093 pubmed: 33346822
Lip G, Genaidy A, Tran G, Marroquin P, Estes C, Shnaiden T, Bayewitz A (2022) Incident and recurrent myocardial infarction (MI) in relation to comorbidities: prediction of outcomes using machine-learning algorithms. Eur J Clin Invest 52(8):e13777. https://doi.org/10.1111/eci.13777
doi: 10.1111/eci.13777 pubmed: 35349732
Lip GYH, Genaidy A, Tran G, Marroquin P, Estes C (2022) Incidence and complications of atrial fibrillation in a low Socioeconomic and high disability United States (US) population: a combined statistical and machine learning approach. Int J Clin Pract 2022:8649050. https://doi.org/10.1155/2022/8649050
doi: 10.1155/2022/8649050 pubmed: 36110264 pmcid: 9448617
Lip GYH, Tran G, Genaidy A, Marroquin M, Estes C, Harrell T (2021) Prevalence/incidence of atrial fibrillation based on integrated medical/pharmacy claims, and association with co-morbidity profiles/multi-morbidity in a large US adult cohort. Int J Clin Pract 75(5):e14042. https://doi.org/10.1111/ijcp.14042
doi: 10.1111/ijcp.14042 pubmed: 33486858
Lip G, Genaidy A, Tran G, Marroquin P, Estes C, Sloop S (2022) Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms. Thromb Haemost 122(1):142–150. https://doi.org/10.1055/a-1467-2993
doi: 10.1055/a-1467-2993 pubmed: 33765685
Lip GYH, Genaidy A, Estes C, McKay D, Falks T (2022) Transient ischemic attack events and incident cardiovascular and non-cardiovascular complications: observations from a large diversified multimorbid cohort. European J Stroke; in press
Henry J. Kaiser foundation. An overview of Medicare. https://files.kff.org/attachment/issue-brief-an-overview-of-medicare . Consulted on 04/18/2023
Fitzgerald M, Saville BR, Lewis RJ (2015) Decision curve analysis. JAMA 313(4):409–410. https://doi.org/10.1001/jama.2015.37
doi: 10.1001/jama.2015.37 pubmed: 25626037
Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol 74(6):796–804. https://doi.org/10.1016/j.eururo.2018.08.038
doi: 10.1016/j.eururo.2018.08.038 pubmed: 30241973 pmcid: 6261531
Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, On behalf of topic group ‘evaluating diagnostic tests and prediction models’ of the STRATOS initiative (2019) Calibration: the achilles heel of predictive analytics. BMC Med 17:230. https://doi.org/10.1186/s12916-019-1466-7
doi: 10.1186/s12916-019-1466-7 pubmed: 31842878 pmcid: 6912996
National Centre for Health Statistics. Health, United States, 2020–2021. Respondent-reported prevalence of heart disease in adults aged 18 and over, by selected characteristics: United States, selected years 1997–2019. https:\\ www.cdc.gov/nchs/hus/data-finder.htm
Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, Van Wagner LB, Wang N-W, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2021) Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 143(8):e254–e743. https://doi.org/10.1161/CIR.0000000000000950
doi: 10.1161/CIR.0000000000000950 pubmed: 33501848
Buckley BJR, Lip GYH (2022) Current concepts: comprehensive “cardiovascular health” rehabilitation-an integrated approach to improve secondary prevention and rehabilitation of cardiovascular diseases. Thromb Haemost 122(12):1966–1968. https://doi.org/10.1055/s-0042-1757403
doi: 10.1055/s-0042-1757403 pubmed: 36307101
Lip GYH, Ntaios G (2022) “Novel clinical concepts in thrombosis”: integrated care for stroke management-easy as ABC. Thromb Haemost 122(3):316–319. https://doi.org/10.1055/a-1632-1777
doi: 10.1055/a-1632-1777 pubmed: 34474499
Field M, Kuduvalli M, Torella F, McKay V, Khalatbari A, Lip GYH (2022) Integrated care systems and the aortovascular hub. Thromb Haemost 122(2):177–180. https://doi.org/10.1055/a-1591-8033
doi: 10.1055/a-1591-8033 pubmed: 34407555
Lip GYH (2017) The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 14(11):627–628. https://doi.org/10.1038/nrcardio.2017.153
doi: 10.1038/nrcardio.2017.153 pubmed: 28960189
Romiti GF, Pastori D, Rivera-Caravaca JM, Ding WY, Gue YX, Menichelli D, Gumprecht J, Kozieł M, Yang P-S, Guo Y, Lip GYH, Proietti M (2022) Adherence to the “Atrial Fibrillation Better Care” pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost 122(3):406–414. https://doi.org/10.1055/a-1515-9630
doi: 10.1055/a-1515-9630 pubmed: 34020488
Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH (2022) 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost 122(1):20–47
doi: 10.1055/s-0041-1739411 pubmed: 34773920
Lip GYH, Ntaios G (2022) Novel clinical concepts in thrombosis: integrated care for stroke management - easy as ABC. Thromb Haemost 122(3):316–319. https://doi.org/10.1055/a-1632-1777
doi: 10.1055/a-1632-1777 pubmed: 34474499
Buckley BJR, Lip GYH (2022) Current concepts: comprehensive “cardiovascular health” rehabilitation - an integrated approach to improve secondary prevention and rehabilitation of cardiovascular diseases. Thromb Haemost 122(12):1966–1968
doi: 10.1055/s-0042-1757403 pubmed: 36307101
Brenn T (2028) Survival to age 90 in men: the Tromso Study 1974–2018. Int J Environ Res Public Health 2019(16):6
Heir T, Erikssen J, Sandvik L (2013) Life style and longevity among initially healthy middle-aged men: prospective cohort study. BMC Public Health 13:8317
doi: 10.1186/1471-2458-13-831
Wilhelmsen L, Svardsudd K, Eriksson H et al (2011) Factors associated with reaching 90 years of age: a study of men born in 1913 in Gothenburg, Sweden. J Int Med 269:441–51.8
doi: 10.1111/j.1365-2796.2010.02331.x
Yates LB, Djousse L, Kurth T, Buring JE, Gaziano JM (2008) Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Int Med 168:284–290
doi: 10.1001/archinternmed.2007.77
Lip GYH, Genaidy A, Jones B, Tran G, Marroquin P, Estes C, Shnaiden T (2023) Adherence levels and patterns for multiple cardiac medications prescribed to patients with incident atrial fibrillation events. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.15627
doi: 10.1111/bcp.15627 pubmed: 36942465
Szymanski T, Ashton R, Sekelj S, Petrungaro B, Pollock KG, Sandler B, Lister S, Hill NR, Farooqui U (2022) Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients. Europace 24(8):1240–1247. https://doi.org/10.1093/europace/euac016
doi: 10.1093/europace/euac016 pubmed: 35226101
Casebeer A, Horter L, Hayden J, Simmons J, Evers T (2021) Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization. J Cardiovasc Med (Hagerstown) 22(1):45–52. https://doi.org/10.2459/JCM.0000000000001116
doi: 10.2459/JCM.0000000000001116 pubmed: 32941326
Yasmin F, Shah SMI, Naeem A, Shujauddin SM, Jabeen A, Kazmi S, Siddiqui SA, Kumar P, Salman S, Hassan SA, Dasari C, Choudhry AS, Mustafa A, Chawla S, Lak HM (2021) Artificial intelligence in the diagnosis and detection of heart failure: the past, present, and future. Rev Cardiovasc Med 22(4):1095–1113. https://doi.org/10.31083/j.rcm2204121
doi: 10.31083/j.rcm2204121 pubmed: 34957756
Polo Friz H, Esposito V, Marano G, Primitz L, Bovio A, Delgrossi G, Bombelli M, Grignaffini G, Monza G, Boracchi P (2022) Machine learning and LACE index for predicting 30-day readmissions after heart failure hospitalization in elderly patients. Intern Emerg Med 17(6):1727–1737. https://doi.org/10.1007/s11739-022-02996-w
doi: 10.1007/s11739-022-02996-w pubmed: 35661313
Bernabeu-Wittel M, Para O, Voicehovska J, Gómez-Huelgas R, Václavík J, Battegay E, Holecki M, EFIM Multimorbidity Working Group (2023) van Munster BC (2023) Competences of internal medicine specialists for the management of patients with multimorbidity. EFIM multimorbidity working group position paper. Eur J Intern Med 109:97–106. https://doi.org/10.1016/j.ejim.2023.01.011
doi: 10.1016/j.ejim.2023.01.011 pubmed: 36653235

Auteurs

Gregory Yoke Hong Lip (GYH)

Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, L7 8TX, UK. gregory.lip@liverpool.ac.uk.
Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. gregory.lip@liverpool.ac.uk.

Ash Genaidy (A)

Anthem Inc, Indianapolis, IN, USA. ashgenaidy@gmail.com.
Anthem Clinical Health Economics Team, Cincinnati, OH, 45249, USA. ashgenaidy@gmail.com.

Cara Estes (C)

Anthem Inc, Indianapolis, IN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH